International Study of Biofield Therapy

NCT03994809 | Completed

• 1 other identifier: MOA-004
• Study Type: observational
• Target: 12,000
• Locations: 0 countries
• Sites: N/A

Brief Summary

Participants from 14 different countries received a single session of biofield therapy (Okada Purifying Therapy) lasting 30 minutes or longer from the volunteer practitioners. Before and after the therapy, they reported the severity of physical pain, anxiety/depression, dizziness/palpitation, and overall symptoms. The team compared the effectiveness/safety of biofield therapy between countries and analyzed the factors associated with the outcomes.

Conditions

Pain; Depression, Anxiety; Dizziness; Signs and Symptoms

Keywords

biofield therapy; ethnic differences; Okada Purifying Therapy; effectiveness; safety

Outcome Measures

Primary Outcomes (2)

• improvement/exacerbation rate of symptoms after a single session of biofield therapy

  The Mann-Whitney test was conducted to compare the improvement/exacerbation rates between countries.

  Up to one year after all the data were collected.

• adjusted odds ratio of the factors associated with the changes in symptoms

  Logistic regression analyses

  Up to one year after all the data were collected.

Interventions

Okada Purifying Therapy OTHER

The practitioner raises his/her hand forward towards the recipient with the palm directed toward the recipient. The practitioner uses his/her hands alternately during the administration of Okada Purifying Therapy. The distance between the palm and the body is usually 1-2 feet, with each session typically lasting 30 to 60 minutes.

Eligibility Criteria

• Age: 16 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Participants were recruited in various settings, including the workshop, the investigator's house, or the participant's home in 14 different countries.

You may qualify if:

• Individuals who agreed to receive a single session of biofield therapy for 30 minutes or longer from the volunteer investigators.
• Individuals who were able to self-evaluate the change of their symptoms.
• Individuals who were competent to answer the questionnaires.
• Individuals who were aged 16 or older.

Sponsors & Collaborators

• MOA Health Science Foundation: lead

Related Publications (1)

• Suzuki K, Uchida S, Kimura T, Tanaka H, Katamura H. International Cross-Sectional Study on the Effectiveness of Okada Purifying Therapy, a Biofield Therapy, for the Relief of Various Symptoms. J Altern Complement Med. 2020 Aug;26(8):708-720. doi: 10.1089/acm.2019.0264. Epub 2020 Jun 17.

  PMID: 32551797 DERIVED

MeSH Terms

Conditions

Pain; Depression; Anxiety Disorders; Dizziness; Signs and Symptoms

Condition Hierarchy (Ancestors)

Neurologic Manifestations; Pathological Conditions, Signs and Symptoms; Behavioral Symptoms; Behavior; Mental Disorders; Sensation Disorders

Study Officials

• Kiyoshi Suzuki, MD, PhD

  MOA Health Science Foundation

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: President

Study Record Dates

• First Submitted: June 17, 2019
• First Posted: June 21, 2019
• Study Start: January 1, 2008
• Primary Completion: September 30, 2010
• Study Completion: September 30, 2010
• Last Updated: June 21, 2019

Record last verified: 2019-06

Data Sharing

• IPD Sharing: Will not share